HIGHLIGHTS
- who: Mar Riveiro-Barciela from the University, Russia have published the Article: Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors, in the Journal: (JOURNAL)
SUMMARY
COPYRIGHT immunotherapy, toxicity, cancer, oncology-discipline, special populations Frontiers in Medicine Editorial on the Research Topic Multidisciplinary management of cancer patients immune-related adverse events from checkpoint inhibitors with Cancer immunotherapy with immune checkpoint inhibitors (ICI) has revolutionized the management of many frequent advanced tumors, such as lung cancer. "Multidisciplinary Management of Cancer Patients with Immune-Related Adverse Events from Checkpoint Inhibitors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.